华侨Huaqiao品牌怎么样 申请店铺

我要投票 华侨Huaqiao在医疗用品行业中的票数:68 更新时间:2024-12-23
华侨Huaqiao是哪个国家的品牌?「华侨Huaqiao」是 吉林省华侨药业集团有限公司 旗下著名品牌。该品牌发源于吉林,由创始人胥凤琴在2004期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
华侨Huaqiao怎么样

吉林省华侨药业有限公司座落在风景秀丽的松花江畔,占地面积60000平米。是一个集片剂(含头孢菌素类)、胶囊剂、颗粒剂、丸剂(大蜜丸、水蜜丸、水丸、浓缩丸、糊丸)、煎膏剂、酒剂等生产、研发为一体的综合性制药企业。

其中我公司现拥有三个全国独家品种:七味消渴胶囊、肠舒胶囊、健脾益血片。治疗心脏病的冠脉宁片、心可宁胶囊、复方丹参片,消除瘙痒痛苦的肤痒颗粒、治疗肺结核疾病的补金片、治疗妇科病的妇科止血灵、女金片、乌鸡白凤丸、鹿胎膏、十全大补丸等,治疗肾病的肾康宁,补肾最佳疗效的三肾丸、男宝胶囊,糖尿病人的福音全国独家品种七味消渴胶囊和糖尿乐片等,治疗儿科的良药小儿清肺止咳片和小儿肺热平胶囊,治疗痈疽疔毒、瘰疬、流注、癌肿的西黄丸。清热解毒的安宫牛黄丸、牛黄清心丸等系列名贵中成药和深受港澳和东南亚国家欢迎的“鹿胎膏”“全鹿丸”市场潜力很大。

本公司拥有国内外先进的生产设备及检测仪器;拥有现代化的领导管理体制、优秀的管理人才和高素质的员工队伍;具有完备的质量管理机构和完善的质量保证监督体系,生产的药品质量有可靠的保证。

公司坚持以人为本、以信誉求发展,创造无限的企业精神;科技领先、质量第一的企业宗旨,多年来不断发展壮大,于2010年11月牵手了“长春万德制药有限公司”、2014年10月收购了通化汇金堂药业有限公司片剂、胶囊剂、颗粒剂三个剂型国药准字号品种,到目前为止公司共拥有10个剂型142个国药准字号品种。

届时,我们真诚欢迎全国各地区、各级代理商与我们合作,形式不限,双方保利,共同发展。

关爱人民健康是我们的追求。本公司将以增进人民健康为至高点,信誉第一,用户至上的原则,与各界朋友真诚合作,共创辉煌。

Jilin overseas Chinese Pharmaceutical Co., Ltd. is located in the beautiful Songhua River, covering an area of 60000 square meters. Is a set of tablets (including cephalosporins), capsules, granules, pills (big honey pill, water honey pill, water pill, concentrated pill, paste pill), decoction, liquor and other production, research and development as one of the comprehensive pharmaceutical enterprises. Among them, our company now has three national exclusive varieties: Qiwei Xiaoke Capsule, Changshu capsule, Jianpi Yixue tablet. Guanguananying tablet, Xinkening capsule and compound danshen tablet for treating heart disease, Fuyang granule for eliminating itching and pain, Bujin tablet for treating tuberculosis, fufu Zhixue Ling, Nujin tablet, Wuji Baifeng pill, deer embryo paste and Shiquan Dabu pill for treating gynecology disease, Shenkangning pill for treating kidney disease, Sanshen pill and manbao capsule for the best effect of tonifying kidney, and the gospel of diabetes patients are exclusive nationwide Qiwei Xiaoke Capsule and tangnialele tablet were used to treat children's Qingfei Zhike tablet and children's feileping capsule, and Xihuang Pill was used to treat carbuncle toxin, scrofula, flow injection and cancer. The famous Chinese patent medicines, such as Angong Niuhuang Pill and Niuhuang Qingxin pill, which can clear away heat and detoxify, and the "deer embryo paste" and "Quanlu pill", which are popular in Hong Kong, Macao and Southeast Asian countries, have great market potential. The company has advanced production equipment and testing instruments at home and abroad; has a modern leadership management system, excellent management personnel and high-quality staff; has a complete quality management organization and a perfect quality assurance supervision system, and the quality of drugs produced has a reliable guarantee. The company adheres to the enterprise spirit of people-oriented, reputation based development and unlimited creation; the enterprise tenet of science and technology leading and quality first has been developing and growing for many years. In November 2010, the company joined hands with "Changchun Wande Pharmaceutical Co., Ltd." and in October 2014, the company acquired three types of national pharmaceutical brands of Tonghua huijintang Pharmaceutical Co., Ltd., namely tablet, capsule and granule. Up to now The company has a total of 10 dosage forms and 142 varieties of national drug approved brands. At that time, we sincerely welcome agents from all regions and all levels of the country to cooperate with us in any form, with both sides making profits and developing together. Caring for people's health is our pursuit. The company will take the promotion of people's health as the highest point, reputation first, the principle of user first, and sincerely cooperate with friends from all walks of life to create brilliant.

本文链接: https://brand.waitui.com/d0c4886e3.html 联系电话:13894909988

千城特选小程序码

7×24h 快讯

贵州茅台:2025年酱香酒公司任务目标为销售额增幅不低于上市公司过去5年平均增速

茅台酱香酒公司总经理陈宗强在今日举行的2025年茅台酱香酒经销商联谊会上表示,2025年,茅台酱香酒公司的任务目标是销售额增速不低于贵州茅台过去5年的平均增速。未来,茅台1935将以500~800元价格段,围绕长三角、珠三角、京津冀等地区精耕。在费用投入方面,茅台酱香酒明年投入费用绝对数较2024年增加15亿元,增幅超50%。(财联社)

7分钟前

华为转让开源鸿蒙商标至开放原子

36氪获悉,企查查App显示,近日,华为技术有限公司将其持有的两枚“开源鸿蒙”商标转让至开放原子开源基金会,国际分类为设计研究,上述商标分别申请于2022年7月、2022年10月。此前,开放原子开源基金会已成功注册多枚“开源鸿蒙”商标,国际分类涉及社会法律、通讯服务、金融物管等。据媒体报道,12月20日,在2024开放原子开发者大会暨首届开源技术学术大会开幕式上,开放原子开源鸿蒙项目群发布了开源鸿蒙操作系统5.0 Release版本。

7分钟前

中船系个股异动拉升,中船科技直线涨停

36氪获悉,截至发稿,中船系个股异动拉升,中船科技直线涨停,中船汉光涨超8%,中船应急、昆船智能、中国船舶等跟涨。

7分钟前

流媒体服务股价飙升,Spotify高管套现获利颇丰

据报道,根据对提交给美国证券交易委员会的文件的分析,Spotify的高管和董事会成员2024年出售了价值12.5亿美元的公司股票,利用这家音乐流媒体公司飙升的股价套现获利颇丰。(界面)

7分钟前

“美克生能源”获数亿元D+轮融资,北京国资领投

36氪获悉,近日,“美克生能源”完成数亿元D+轮融资。本轮融资由北京市绿色能源和低碳产业投资基金领投,北京未来科学城先进能源和智能制造产业股权投资基金跟投。据介绍,美克生能源是面向新型电力系统的分布式绿色能源聚合服务商。

7分钟前

本页详细列出关于东阳光HEC的品牌信息,含品牌所属公司介绍,东阳光HEC所处行业的品牌地位及优势。
咨询